RhumbLine Advisers’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Buy
216,933
+1,192
+0.6% +$10.7K ﹤0.01% 1813
2025
Q4
$1.83M Sell
215,741
-1,851
-0.9% -$13.2K ﹤0.01% 1922
2025
Q3
$1.14M Sell
217,592
-4,261
-2% -$16.2K ﹤0.01% 2176
2025
Q2
$768K Buy
221,853
+47,728
+27% +$142K ﹤0.01% 2382
2025
Q1
$456K Buy
174,125
+2,681
+2% +$10.5K ﹤0.01% 2636
2024
Q4
$706K Buy
171,444
+13,532
+9% +$73.6K ﹤0.01% 2445
2024
Q3
$1.12M Sell
157,912
-5,983
-4% -$44.7K ﹤0.01% 2207
2024
Q2
$1.07M Buy
163,895
+7,508
+5% +$51.3K ﹤0.01% 2204
2024
Q1
$1.3M Buy
156,387
+4,942
+3% +$48.2K ﹤0.01% 2113
2023
Q4
$1.67M Sell
151,445
-1,732
-1% -$14.6K ﹤0.01% 2002
2023
Q3
$1.29M Buy
153,177
+4,771
+3% +$51.3K ﹤0.01% 2070
2023
Q2
$1.86M Buy
148,406
+12,846
+9% +$160K ﹤0.01% 1945
2023
Q1
$2.23M Buy
135,560
+6,696
+5% +$120K ﹤0.01% 1745
2022
Q4
$1.93M Buy
128,864
+10,305
+9% +$197K ﹤0.01% 1805
2022
Q3
$2.65M Buy
118,559
+8,122
+7% +$178K ﹤0.01% 1617
2022
Q2
$1.85M Buy
110,437
+34,999
+46% +$750K ﹤0.01% 1800
2022
Q1
$2.26M Buy
75,438
+5,437
+8% +$132K ﹤0.01% 1752
2021
Q4
$2.15M Buy
70,001
+8,260
+13% +$261K ﹤0.01% 1839
2021
Q3
$1.95M Buy
61,741
+2,876
+5% +$96.8K ﹤0.01% 1922
2021
Q2
$2.15M Buy
58,865
+8,583
+17% +$283K ﹤0.01% 1916
2021
Q1
$1.74M Buy
50,282
+9,902
+25% +$430K ﹤0.01% 1973
2020
Q4
$1.68M Buy
40,380
+3,771
+10% +$170K ﹤0.01% 1931
2020
Q3
$1.56M Buy
+36,609
New +$1.4M ﹤0.01% 1808

Other funds holding RLAY